Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/iid3.367 http://scihub22266oqcxt.onion/10.1002/iid3.367 33320447!7860591!33320447     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Immun+Inflamm+Dis 2021 ; 9 (1): 128-133 Nephropedia Template TP {{tp|p=33320447|t=2021. Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2 |pdf=|usr=}}{{33320447}} gab.com Text Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2 JO: Immun Inflamm Dis http://www.kidney.de/pget.php?&tw=1&pmid=33320447 #FOAvip BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged throughout the world. Building knowledge around Covid-19 is crucial to devise facts based approaches to respond efficiently against this pandemic. AIM: We aimed to investigate pre-existing humoral cross-reactive immunity to SARS-CoV-2. METHOD: We have tested the reactivity against SARS-CoV-2 nucleocapsid (N) antigen of sera collected from healthy healthcare volunteers in 2014. We assessed immunoglobulins reactive against SARS-CoV-2 N-antigen using a well-validated serological platform; Elecsys assay. RESULTS: Sera from 32 subjects (out of 135 [23.7%]) were reactive to SARS-CoV-2 N-antigen, suggesting the presence of anti-SARS-CoV-2 N-antigen antibodies. CONCLUSION: Although the clinical relevance of the observed reactivity can only be speculated and needs to be investigated, the implication of this finding for coronavirus disease 2019 seroepidemiological survey and vaccines' clinical trials is critical. Twit Text FOAVip Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2 ????Immun Inflamm Dis http://www.kidney.de/pget.php?&tw=1&pmid=33320447 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33320447 #FOAvip English Wikipedia <ref>{{Cite pmid|33320447}}</ref> Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2 #MMPMID33320447 Mveang Nzoghe A; Essone PN; Leboueny M; Maloupazoa Siawaya AC; Bongho EC; Mvoundza Ndjindji O; Avome Houechenou RM; Agnandji ST; Djoba Siawaya JF Immun Inflamm Dis 2021[Mar]; 9 (1): 128-133 PMID33320447show ga BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged throughout the world. Building knowledge around Covid-19 is crucial to devise facts based approaches to respond efficiently against this pandemic. AIM: We aimed to investigate pre-existing humoral cross-reactive immunity to SARS-CoV-2. METHOD: We have tested the reactivity against SARS-CoV-2 nucleocapsid (N) antigen of sera collected from healthy healthcare volunteers in 2014. We assessed immunoglobulins reactive against SARS-CoV-2 N-antigen using a well-validated serological platform; Elecsys assay. RESULTS: Sera from 32 subjects (out of 135 [23.7%]) were reactive to SARS-CoV-2 N-antigen, suggesting the presence of anti-SARS-CoV-2 N-antigen antibodies. CONCLUSION: Although the clinical relevance of the observed reactivity can only be speculated and needs to be investigated, the implication of this finding for coronavirus disease 2019 seroepidemiological survey and vaccines' clinical trials is critical. |*Immunity, Humoral[MESH] |Adult[MESH] |Antibodies, Viral/blood/immunology[MESH] |COVID-19/*immunology/*virology[MESH] |Cross Reactions/*immunology[MESH] |Female[MESH] |Host-Pathogen Interactions/*immunology[MESH] |Humans[MESH] |Immunologic Memory[MESH] |Male[MESH] |Middle Aged[MESH] |SARS-CoV-2/*immunology[MESH]Evidence and implications of pre-existing humoral cross-reactive immun(epmc).pdf DeepDyve Pubget Overpricing